AntriaBio, Inc. (OTCPK:ANTB) announced that it has entered into stock purchase agreement for a private placement of 15,000,000 common shares at a price of $1 per share for gross proceeds of $15,000,000 on March 6, 2017. The securities will be issued pursuant to exemption provided under Regulation D. The company will close the transaction in tranches.

On the same date, the company announced that it has issued 4,500,000 common shares for gross proceeds of $4,500,000 in its first tranche. The tranche included participation from investors from the Republic of Korea and the United States.